Multidrug-resistant Acinetobactor baumannii isolated from a traveler returned from Brunei

Journal of Infection and Chemotherapy

Volumn 21, Issue 3, 2015, Pages 212-214

  Tojo, Masayoshi ^a,b,c   Mawatari, Momoko ^b   Hayakawa, Kayoko ^b   Nagamatsu, Maki ^b,c   Shimada, Kayo ^c   Mezaki, Kazuhisa ^d   Sugiki, Yuko ^d   Kuroda, Emi ^d   Takeshita, Nozomi ^b   Kutsuna, Satoshi ^b   Fujiya, Yoshihiro ^b   Miyoshi Akiyama, Tohru ^c   Kirikae, Teruo ^c   Ohmagari, Norio ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Disease Control and Prevention Center   (Japan)

^c Building Research Institute   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

16S rRNA methylase; Acinetobacter baumannii; Antimicrobial resistance; armA; bla OxA 23; Carbapenemase

Indexed keywords

AMIKACIN; AZITHROMYCIN; AZTREONAM; CASPOFUNGIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFRADINE; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; FLUCONAZOLE; FOSFOMYCIN; GENTAMICIN; HABEKACIN; IMIPENEM; MEROPENEM; MINOCYCLINE; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; BETA-LACTAMASE OXA-23, ACINETOBACTER BAUMANNII; METHYLTRANSFERASE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTHRALGIA; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM ISOLATE; BROTH DILUTION; BRUNEI DARUSSALAM; CANDIDIASIS; CASE REPORT; CATHETER INFECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DIABETES MELLITUS; DISEASE COURSE; DRUG DOSE REDUCTION; FATIGUE; FEVER; FLU LIKE SYNDROME; GENERAL CONDITION DETERIORATION; HUMAN; INTENSIVE CARE UNIT; JAPAN; KLEBSIELLA PNEUMONIAE; LOSS OF APPETITE; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PATIENT TRANSPORT; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PLEURA EFFUSION; PNEUMONIA; RHINORRHEA; SEPSIS; SORE THROAT; THORAX RADIOGRAPHY; TRACHEOSTOMY; TRAVEL; VENTILATOR ASSOCIATED PNEUMONIA; ACINETOBACTER INFECTIONS; BACTEREMIA; ENZYMOLOGY; EPIDEMIOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PNEUMONIA, BACTERIAL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAMASES; BRUNEI; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MALE; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; PNEUMONIA, BACTERIAL; TRAVEL;

EID: 84946202294     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2014.08.029     Document Type: Article

References (24)

1. Kwon K.T., Oh W.S., Song J.H., Chang H.H., Jung S.I., Kim S.W., et al. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J Antimicrob Chemother 2007, 59:525-530.
2. Sunenshine R.H., Wright M.O., Maragakis L.L., Harris A.D., Song X., Hebden J., et al. Multidrug-resistant acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 2007, 13:97-103.
3. Lockhart S.R., Abramson M.A., Beekmann S.E., Gallagher G., Riedel S., Diekema D.J., et al. Antimicrobial resistance among gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J Clin Microbiol 2007, 45:3352-3359.
4. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
5. Domingues S., Harms K., Fricke W.F., Johnsen P.J., da Silva G.J., Nielsen K.M. Natural transformation facilitates transfer of transposons, integrons and gene cassettes between bacterial species. PLoS Pathog 2012, 8:e1002837.
6. Munoz-Price L.S., Weinstein R.A. Acinetobacter infection. N Engl J Med 2008, 358:1271-1281.
7. Wachino J., Arakawa Y. Exogenously acquired 16S rRNA methyltransferases found in aminoglycoside-resistant pathogenic gram-negative bacteria: an update. Drug Resist Updat 2012, 15:133-148.
8. Tada T., Miyoshi-Akiyama T., Dahal R.K., Mishra S.K., Ohara H., Shimada K., et al. Dissemination of multidrug-resistant Klebsiella pneumoniae clinical isolates with various combinations of carbapenemases (NDM-1 and OXA-72) and 16S rRNA methylases (ArmA, RmtC and RmtF) in Nepal. Int J Antimicrob Agents 2013, 42:372-374.
9. Tada T., Miyoshi-Akiyama T., Shimada K., Shimojima M., Kirikae T. Dissemination of 16S rRNA methylase ArmA-producing Acinetobacter baumannii and emergence of OXA-72 carbapenemase coproducers in Japan. Antimicrobial Agents Chemother 2014, 58:2916-2920.
10. Clinical Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard M07-A7 2009, Wayne, PA. 8th ed.
11. Vila J., Ruiz J., Goñi P., Marcos A., Jimenez de Anta T. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrobial Agents Chemother 1995, 39:1201-1203.
12. Vila J., Ruiz J., Goñi P., De Anta M.T. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrobial Agents Chemother 1996, 40:491-493.
13. Hamouda A., Amyes S.G.B. Novel gyrA and parC point mutations in two strains of Acinetobacter baumannii resistant to ciprofloxacin. J Antimicrob Chemother 2004, 54:695-696.
14. Park S., Lee K.M., Yoo Y.S., Yoo J.S., Il Yoo J., Kim H.S., et al. Alterations of gyrA, gyrB, and parC and activity of efflux pump in fluoroquinolone-resistant Acinetobacter baumannii. Osong Public Health Res Perspect 2011, 2:164-170.
15. Karageorgopoulos D.E., Falagas M.E. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008, 8:751-762.
16. Tzouvelekis L.S., Markogiannakis A., Psichogiou M., Tassios P.T., Daikos G.L. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 2012, 25:682-707.
17. Hashimoto A., Nagamatsu M., Ohmagari N., Kayoko, Hayakawa Yasuyuki K., Teruo K. Isolation of OXA-48 carbapenemase-producing Klebsiella pneumoniae ST101 from an overseas traveler returning to Japan. Jpn J Infect Dis 2014, 67:120-121.
18. Wang X., Qiao F., Yu R., Gao Y., Zong Z. Clonal diversity of Acinetobacter baumannii clinical isolates revealed by a snapshot study. BMC Microbiol 2013, 13:234.
19. Strateva T., Markova B., Marteva-Proevska Y., Ivanova D., Mitov I. Widespread dissemination of multidrug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase and ArmA 16S ribosomal RNA methylase in a Bulgarian university hospital. Braz J Infect Dis 2012, 16:307-310.
20. Bonnin R.A., Potron A., Poirel L., Lecuyer H., Neri R., Nordmann P. PER-7, an extended-spectrum beta-lactamase with increased activity toward broad-spectrum cephalosporins in Acinetobacter baumannii. Antimicrobial Agents Chemother 2011, 55:2424-2427.
21. Karthikeyan K., Thirunarayan M.A., Krishnan P. Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J Antimicrob Chemother 2010, 65:2253-2254.
22. Kim J.W., Heo S.T., Jin J.S., Choi C.H., Lee Y.C., Jeong Y.G., et al. Characterization of Acinetobacter baumannii carrying bla(OXA-23), bla(PER-1) and armA in a Korean hospital. Clin Microbiol Infect 2008, 14:716-718.
23. Karah N., Haldorsen B., Hermansen N.O., Tveten Y., Ragnhildstveit E., Skutlaberg D.H., et al. Emergence of OXA-carbapenemase- and 16S rRNA methylase-producing international clones of Acinetobacter baumannii in Norway. J Med Microbiol 2011, 60:515-521.
24. Doi Y., Adams J.M., Yamane K., Paterson D.L. Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America. Antimicrobial Agents Chemother 2007, 51:4209-4210.